Cobinamide inhibits osteoclastogenesis and alveolar bone resorption in periodontitis
Journal of Periodontal & Implant Science · 2026 · 56
DOI: 10.5051/jpis.2505520276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontal & Implant Science, 2026. Verfasst von Jiwon Seok und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Dentistry, Kyungpook National University, Daegu, Korea. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, US National Institutes of Health.
Abstract (Originalsprache)
PURPOSE: Periodontitis is an inflammatory disease of the hard and soft tissues surrounding the teeth and is initiated by bacterial biofilms. Severe alveolar bone resorption often occurs because of marked increases in osteoclast number and activity, which can ultimately lead to tooth loss. Recent evidence suggests that reactive oxygen species (ROS) may act as a common mediator of both osteoclastogenesis and inflammation. METHODS: We examined the effect of the potent antioxidant cobinamide, a vitamin B₁₂ derivative, on osteoclast differentiation from mouse bone marrow macrophage (BMM) precursors in culture and on bone resorption and inflammation in a mouse model of ligature-induced periodontitis. RESULTS: At submicromolar concentrations, cobinamide significantly reduced receptor activator of nuclear factor κB ligand-dependent differentiation of osteoclasts from mouse BMM precursors. In addition, cobinamide rapidly and almost completely abrogated ROS generation and Ca²⁺ oscillations in differentiating osteoclasts, both of which are essential for osteoclastogenesis. Local application of cobinamide in a hydrogel significantly reduced alveolar bone resorption in the ligature-induced periodontitis model, concomitant with a marked reduction in osteoclast number and activity. Furthermore, cobinamide prevented ligature-induced oxidative tissue damage while simultaneously reducing T-cell and macrophage recruitment and the production of interleukin-1β, interleukin-6, and tumor necrosis factor-α. CONCLUSIONS: These results indicate that cobinamide has anti-osteoclastogenic and anti-inflammatory effects in periodontitis, suggesting its potential clinical utility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, School of Dentistry, Kyungpook National University, Daegu, Korea.
- Department of Oral Microbiology, School of Dentistry, Kyungpook National University, Daegu, Korea.
- Department of Periodontology, School of Dentistry, Kyungpook National University, Daegu, Korea.
- Department of Medicine, University of California, San Diego, CA, USA.
- Department of Medicine, University of California, San Diego, CA, USA. gboss@ucsd.edu.
- Department of Biochemistry, School of Dentistry, Kyungpook National University, Daegu, Korea. ylee@knu.ac.kr.
ORCID-Profile: Jiwon Seok, Heon-Jin Lee, Yong-Gun Kim, Shyamsundar Pal China, Renate B Pilz, Gerry R Boss, Youngkyun Lee
Förderung
- National Research Foundation of Korea
- US National Institutes of Health
Zitieren
APA
Seok, J., Kim, H. J., Ryu, K. Y., Lee, H. J., Kim, Y. G., Kalyanaraman, H., China, S. P., Pilz, R. B., Boss, G. R., & Lee, Y. (2026). Cobinamide inhibits osteoclastogenesis and alveolar bone resorption in periodontitis. Journal of Periodontal & Implant Science, 56. https://doi.org/10.5051/jpis.2505520276
Vancouver
Seok J, Kim HJ, Ryu KY, Lee HJ, Kim YG, Kalyanaraman H, et al. Cobinamide inhibits osteoclastogenesis and alveolar bone resorption in periodontitis. Journal of Periodontal & Implant Science. 2026;56. doi:10.5051/jpis.2505520276
BibTeX
@article{Seok2026,
author = {Seok, Jiwon and Kim, Hyo Jeong and Ryu, Ka-Young and Lee, Heon-Jin and Kim, Yong-Gun and Kalyanaraman, Hema and China, Shyamsundar Pal and Pilz, Renate B and Boss, Gerry R and Lee, Youngkyun},
title = {Cobinamide inhibits osteoclastogenesis and alveolar bone resorption in periodontitis},
journal = {Journal of Periodontal & Implant Science},
year = {2026},
volume = {56},
doi = {10.5051/jpis.2505520276}
}
EUVIMED